These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23488553)

  • 1. Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis.
    Sakai K; Fukami K; Yamagishi S; Kaida Y; Adachi T; Ando R; Manabe R; Otsuka A; Sugi K; Ueda S; Okuda S
    Rejuvenation Res; 2013 Jun; 16(3):200-5. PubMed ID: 23488553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Minami A; Nakayama Y; Ando R; Obara N; Ueda S; Wada Y; Okuda S
    Aging Male; 2014 Dec; 17(4):238-42. PubMed ID: 24611884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.
    Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S
    Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
    Lapolla A; Flamini R; Lupo A; Aricò NC; Rugiu C; Reitano R; Tubaro M; Ragazzi E; Seraglia R; Traldi P
    Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine depletion during chronic hemodialysis: effect of substitution on free carnitine plasma levels.
    Broquet PE; Von Moos C; Frei J; Gobelet C; Wauters JP
    Adv Exp Med Biol; 1987; 223():287-90. PubMed ID: 3447448
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced carnitine palmitoyl transferase activity and altered acyl-trafficking in red blood cells from hemodialysis patients.
    de los Reyes B; Perez-García R; Liras A; Arenas J
    Biochim Biophys Acta; 1996 Jan; 1315(1):37-9. PubMed ID: 8611644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis.
    Maebashi M; Imamura A; Yoshinaga K; Sato T; Funyu T; Ishidoya Y; Hirayama N
    Tohoku J Exp Med; 1983 Jan; 139(1):33-42. PubMed ID: 6836557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis.
    Penn D; Schmidt-Sommerfeld E
    Metabolism; 1983 Aug; 32(8):806-9. PubMed ID: 6865778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.
    Tahara N; Imaizumi T; Takeuchi M; Yamagishi S
    Oxid Med Cell Longev; 2010; 3(4):262-5. PubMed ID: 20972372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Adachi T; Ando R; Okuda S
    Rejuvenation Res; 2013 Dec; 16(6):460-6. PubMed ID: 23909402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum endorphin levels in uremic patients under maintenance hemodialysis.
    Hwang JC; Hsu KT; Tsai HC; Lam KK; Wang PW
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):360-5. PubMed ID: 2529347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
    Alhomida AS
    Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine action on red blood cell osmotic resistance in hemodialysis patients.
    Vlassopoulos DA; Hadjiyannakos DK; Anogiatis AG; Evageliou AE; Santikou AV; Noussias CV; Papandreou PT; Hadjiconstantinou VE
    J Nephrol; 2002; 15(1):68-73. PubMed ID: 11936429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients.
    Wanner C; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Am J Clin Nutr; 1990 Mar; 51(3):407-10. PubMed ID: 2309647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.